tiprankstipranks
Benitec Biopharma Ltd (BNTC)
NASDAQ:BNTC
US Market
BNTC
Benitec Biopharma
RESEARCH TOOLSreports
Want to see BNTC full AI Analyst Report?

Benitec Biopharma (BNTC) Stock News & Sentiment

315 Followers
Reiterating Buy on Benitec: Promising Early BB-301 Data in OPMD Underpin $32 12‑Month Target
Premium
Ratings
Reiterating Buy on Benitec: Promising Early BB-301 Data in OPMD Underpin $32 12‑Month Target
2M ago
BNTC
Benitec Biopharma: Emerging BB-301 Clinical Profile and Upcoming Data Catalyst Support Buy Rating and $32 Target
Premium
Ratings
Benitec Biopharma: Emerging BB-301 Clinical Profile and Upcoming Data Catalyst Support Buy Rating and $32 Target
2M ago
BNTC
Benitec Biopharma Concludes 2025 Annual Stockholders Meeting
Premium
Company Announcements
Benitec Biopharma Concludes 2025 Annual Stockholders Meeting
5M ago
8K
BNTC
Benitec Biopharma: Strong Financial Position and Promising Clinical Developments Justify Buy Rating
Premium
Ratings
Benitec Biopharma: Strong Financial Position and Promising Clinical Developments Justify Buy Rating
6M ago
BNTC
Benitec Biopharma Reports Increased Quarterly Loss Amid Rising Expenses
Premium
Company Announcements
Benitec Biopharma Reports Increased Quarterly Loss Amid Rising Expenses
6M ago
BNTC
Benitec Biopharma Announces $100 Million Public Offering
Premium
Company Announcements
Benitec Biopharma Announces $100 Million Public Offering
6M ago
8K
BNTC
Positive Buy Rating for BB-301 Driven by Promising Trial Results and Potential Market Acceleration
Premium
Ratings
Positive Buy Rating for BB-301 Driven by Promising Trial Results and Potential Market Acceleration
6M ago
BNTC
More BNTC News >

BNTC News on the Web

Suvretta Capital Management, LLC Increases Stake in Lexeo Therapeutics Inc
GuruFocus News
Neutral
Reiterating Buy on Benitec: Promising Early BB-301 Data in OPMD Underpin $32 12‑Month Target
TipRanks News
Bullish
Benitec Biopharma announces interim Phase 1b/2a study of BB-301
TipRanks News
Neutral
Benitec Biopharma: Emerging BB-301 Clinical Profile and Upcoming Data Catalyst Support Buy Rating and $32 Target
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: Disc Medicine (IRON) and Benitec Biopharma (BNTC)
TipRanks News
Bullish
Benitec (BNTC) Advances BB-301 Program with Promising Safety and Efficacy
GuruFocus News
Bullish
Benitec Biopharma reports Q2 EPS (26c) vs (26c) last year
TipRanks News
Bullish
Franklin Resources Inc. Expands Stake in Benitec Biopharma Inc.
GuruFocus News
Bullish

News Score - Last 7 Days

Neutral
BNTC
Sector Average
Media Buzz
This Week1 articles
Weekly Average1 articles
News Sentiment
This Week50%
Sector Average70%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is BNTC’s Media Buzz Sentiment?
1 articles about BNTC were published this week. In an average week, 1 articles are published.
    What is BNTC’s weekly average amount of articles?
    In an average week, 1 articles about BNTC are published.
      What is BNTC’s News Sentiment?
      50% of articles about BNTC were positive this week, compared to its sector average of 70%.
        Healthcare Stocks that are Trending in the News
        TVTXTravere Therapeutics
        HVOOpen Orphan Plc
        PBMPsyence Biomedical
        QDELQuidelOrtho
        Showing the stocks with the most bullish news sentiment over the past week